31
Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:September 17, 2013Unknown status
Stage III Multiple Myeloma: 436 Clinical Trials, Page 4 of 44
Hide Studies Not Open or Pending
32
Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:January 16, 2014Completed
33
Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:May 17, 2011Completed
34
Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:August 17, 2020Completed
35
Bortezomib, Doxorubicin Hydrochloride Liposome, and Thalidomide as First-line Therapy in Treating Patients With Previously Untreated Stage I, II, or III Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:February 23, 2017Completed
36
2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors
Condition(s):Refractory Multiple Myeloma; Stage III Multiple Myeloma; Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:January 16, 2013Completed
37
Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma
Condition(s):Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:February 6, 2020Completed
38
Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell Neoplasm; NeurotoxicityLast Updated:August 19, 2021Completed
39
Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:October 11, 2019Completed
40
Bortezomib Before Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma
Condition(s):Multiple Myeloma; Refractory Multiple MyelomaLast Updated:January 5, 2023Withdrawn